Abstract
Patients with leukemia and hyperleukocytosis are at risk of developing leukostasis [1]. Patients with acute myeloid leukemia (AML) will tend to develop symptoms of leukostasis at a white blood count (WBC) of 100000/μl. Patients with chronic myelocytic leukemia (CML) will tend to develop symptoms of leukostasis at a higher WBC of over 200000/μL Patients with acute lymphocytic leukemia (ALL) and hyperleukocytosis have a poorer prognosis than patients with a lower WBC but leukostasis is not a common finding. Patients with chronic lymphocytic leukemia (CLL) very rarely develop symptoms from hyperleukocytosis unless the WBC is extremely elevated e.g. 400000/μl. Leukostasis was reported by us in a single patient with hairy cell leukemia and a WBC of 1 million/μl [2].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Freireich EJ, Thomas LB, et al: A distinctive type of intracerebral hemorrhage associated with ‘blastic crisis’ in patients with leukemia. Cancer 13:146–000, 1960.
Worsley A, Cuttner J, Gordon R, Reilly M, Ambinder EP, Conjalka M: Therapeutic leukapheresis in a patient with hairy cell leukemia. Transfusion 22:308–310, 1982.
Fritz RD, Forkner CE Jr, Freireich EJ, Frei E III, Thomas LB: The association of fatal intracranial hemorrhage and ‘blastic SCRISIS’ in patient with acute leukemia. N Eng J Med 59:261, 1959.
Vernant JP, Brum B, Mannoni P, Dreyfus B: Respiratory distress of hyperleukocytic granulocytic leukemias. Cancer 44:264–268, 1979.
Cuttner J, Conjalka MS, Reilly M, Goldberg J, Reisman A, Meyer RJ, Holland JF: Association of monocytic leukemias in patients with extreme leukocytosis. Amer J Med 69:555–558, 1980.
Tobelman G, Jacquillat C, Chastang C, Auclerc MF, Lecheravallier T, Weil M, Daniel MT, Flandrin G, Harrousseau SL, Schaison G, Boiran M, Bernard J: Acute monoblastic leukemia: A clinical and biologic study of 74 cases. Blood 55:71–76, 1980.
Pulen DJ, et al.: Southwest Oncology Group experience with immunological phenotyping in acute lymphocytic leukemia in childhood. Cancer Res 41:4801–4809, 1981.
Bennett JM, Catovsky D, Daniel MT, Flandren F, Galton DAG, Gralnick HR, Sultan C: Proposals for the classification of acute leukemia. Br J Haematol 33:451–000, 1976.
Meyer RJ, Ferreira PPC, Cuttner J, Greenberg ML, Goldberg J, Holland JF: Central nervous system involvement at presentation in acute granulocytic leukemia: a prospective cytocentrifuge study. Am J Med 68:691–694, 1980.
Grund FM, Armitage JO, Burns CP: Hydroxyurea in the prevention of the effects of leukostasis in acute leukemia. Arch int Med 137:1246–1247, 1977.
Cuttner J, Holland JF, Norton L, Ambinder E, Button G, Meyer RJ: Therapeutic Leukapheresis for hyperleukocytosis in acute myelocytic leukemia. Med & Pediat Oncol 2:76–78, 1983.
Dutcher SP, Schiffer CA, Wesley M: Wiernik PH. Effect of hyperleukocytosis in acute leukemia on remission rate, duration and survival. Proc ASCO. 22:491, 1981.
McKee C Jr, Collins RD: Intravascular leukocyte thrombi and aggregates as a cause of morbidity and mortality in leukemia. Medicine 53(6): 463–478, 1974.
Rowe JM, Lichtman MA: Hyperleukocytosis and leukostasis in children CML: A common presentation of an uncommon disease. Blood 60:136a, 1982.
Lui PI, Ishimaru T, McGregor DH, Ohadt H, Steer A: Autopsy study of granulocytic sarcoma (Chloroma) in patients with myelogenous leukemias. Hiroshima-Nagasaki 1949–1969, Cancer 31:948–955, 1973.
Preston FE, Sokol RJ, Lileyman JS, Winfield DA, Blackburn EK: Cellular hyperviscosity as a cause of neruological symptoms in leukemia. Brit Med J 1:476–478, 1978.
Karp DD, Beck RJ, Cornell CJ: Chronic granulocytic leukemias with respiratory distress. Arch Intern Med 141:1353–1354, 1981.
Old JN, Smith WW, Grampa G: Human lung in leukemia — observations on alveolar capillary leukostasis with refrence to pathologic physiology. Am J Path 31:605, 1955.
Vernant JP, Brun B, Mannoni P, Dreyfus B: Respiratory distress of hyperleukocytic leukemias. Cancer 44:264–268, 1979.
Frost T, Isister JP, Rauch RBM: Respiratory failure due to leukostasis in leukemia. Med Jour of Aust 94–95, Juli 1981.
Bloom R, DaSilva AMT, Bracey A: Reversible respiratory failure due to intravascular leukostasis in chronic myelogenous leukemia. Am J Med 67:679–683, 1979.
Qterling A, Parker A: Leukopheresis for papilledema in chronic granulocytic leukaemia. Brit Med Jour 676–677, 216088; 10 Sept 1977.
Stephens DJ: Relation of viscosity of blood to leukocyte count, with particular reference to chronic myelogenous leukemia. Proc Soc Exp Biol Med 1936, PP 251–156.
Hine JF, Kingham JD: Myelogenous leukemia and bilateral Exudative retinal detachment. Annals of Opthalmology 11A12:1867–1872, 1979.
Ellis LO, Little HG: Leukemic infiltration of the optic nerve head. Am J Opthal 75:867–871, 1973.
Prolla JC, Kusnen JB: The gastrointestinal lesions and complictions of the leukemias. Ann Inter Med 61:1084–1103, 1969.
Datla DU, Grover SL, Saini VC, Datta BD, Aikat BK, Chhuttani: Portal Hypertension in chronic leukemia. Brit Jour Haem 31:279–285, 1955.
Suri R, Goldman JM: Catovsky D, Johnson SA, Wiltshaw E, Galton DAG: Priapism complicating chronic granulocytic leukemia. Amer Jour Hemat 9:298–299, 1980.
Steinberg MH, Charm SE: Effect of high concentration of leukocytes on whole blood viscosity. Blood 38:299–301, 1971.
Lichtman MA, Gregory A, Kearney E: Rheology of leukocytes, leukocyte suspensions, and blood in leukemia. J Clin. Invest 52:350–358, 1973.
Vallejos CS, McCredie KB, Britten GM, Freireich EJ: Biological effects of repeated leukopheresis of patients with chronic myelogenous leukemias Blood 41(6): 928–933, 1973.
Chessells JM: Acute lymphoblastic leukemia. Seminars in Hematology 19:155–171, 1982.
Zippin C, Cutler SJ, Reeves WJ, Jr, Lum D: Variation in survival among patients with acute lymphocytic leukemia. Blood 37:59–72, 1971.
Jacquillat CI, Weil M, Gemon MF, Izrael V, Schaison G, Auclerc G, Abiin AR, Flandrin G, Tanzer J, Bussel A, Weisgerber C, Dresch C, Najean Y, Goudemand M, Seligmann M, Boiron M, Bernard J: Evaluation of 216 four-year survivors of acute leukemia. Cancer 32:286–293, 1973.
Till MM, Hardisty RM: Long survivals in acute leukemia. Lancet i:534–538, 1973.
Gee TS, Haghbin M, Dowling MD Jr, Cunningham I, Middleman MP, Clarkson BD: Acute lymphoblastic leukemia in adults and children. Cancer 37:1256–1264, 1976.
Shaw MT, Raab SO: Adriamycin in combination chemotherapy of adult acute lymphoblastic leukemia. A Southwest Oncology Group Study. Med & Ped One 3:261–266, 1977.
Lister TA, Whitehouse JMA, Beard MEJ, Brearley RL, Wrigley PFM, Oliver RTD, Freeman JE, Woodruff RK, Malpas JS, Paxton AM, Crowther D: Combination chemotherapy for acute lymphoblastic leukemia in adults. Brit M J i: 199–203, 1978.
Omura GA, Moffitt S, Vogler WR, Salter MM: Combination chemotherapy of adult acute lymphoblastic leukemia with randomized central nervous system prophylaxis. Blood 55:199–204, 1980.
Harousseau JL, Tobelem G, Schaison G, Chastang CI, Auclerc MF, Weil M, Jacquillat CI, Bernard J: High risk acute lymphocytic leukemia: A study of 141 cases with initial white blood cell counts over 100,000/cu mm. Cancer 46:1996–2003, 1980.
Leimert JT, Burns CP, Wiltse CG, Armitage JO, Clarke WR: Prognostic influence of pretreatment characteristics in adult acute lymphoblastic leukemia. Blood 56:510–515, 1980.
Baccarini M, Corbelli G, Amadori S, Drenthe-Schonk A, Wilemze R, Meloni G, Cardozo PL, Haanen C, Mandelli F, Tura S: Adolescent and adult acute lymphoblastic leukemia: Prognostic features and outcome of therapy. A study of 293 patients. Blood 60:677–684, 1982.
Wiernik PH, Serpick AA: Factors effecting remission and survival in adult nonlymphocytic leukemia (ANNL). Med 49:505–513, 1970.
Hoagland HC, Perry MC: Blast cell crisis in acute or chronic leukemia. JAMA 235:1888–1889, 1976.
Grund FM, Armitage JO, Burns CP: Hydroxyurea in the prevention of the effects of leukostasis in acute leukemia. Arch Int Med 137:1246–1247, 1977.
Ambinder EP, Cuttner J, Harris MA, Button GR, Holland JF: Therapeutic lymphapheresis for acute lymphocytic leukemia and elevated white blood cell counts. Proc Am Soc Clin One 1982.
Fortuny EE, Haddock DK, Kennedy BJ, Theologides J, McCullough J: The role of continuous flow centrifuge leukapheresis in the management of chronic lymphocytic leukemia. Brit J Haem 32:609–615, 1976.
Goldfinger D, Thompson R, Lowe C, Kurz L, Beiken G: Long-term plateletpheresis in the manegement of primary thrombocytosis. Trans 19:336–338, 1979.
Lowenthal RM, Bushard NA, Goldman JM, Spies SD, Bergier H, Graubner M, Galton DAG: Intensive leukopheresis as initial therapy for chronic granuocytic leukemia. Blood 46:835–844, 1975.
Lane TA: Continuous-flow leukapheresis for rapid cytoreduction in leukemia. Transf. 20:455–457, 1980.
Kamen BA, Summers CP, Pearson HA: Exchange transfusion as a treatment for hyperleukocytosis, anemia, and metabolic abnormalities in a patient with leukemia. J Peds 96:1045–1046, 1980.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Martinus Nijhoff Publishers, Boston
About this chapter
Cite this chapter
Cuttner, J., Meyer, R., Ambinder, E.P., Young, TN. (1985). Hyperleukocytosis in Adult Leukemia. In: Bloomfield, C.D. (eds) Chronic and Acute Leukemias in Adults. Cancer Treatment and Research, vol 26. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2581-9_9
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2581-9_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9619-5
Online ISBN: 978-1-4613-2581-9
eBook Packages: Springer Book Archive